Circulating tumour necrosis factor-alpha bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response. [electronic resource]
Producer: 20060324Description: R149-55 p. digitalISSN:- 1478-6362
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Arthritis, Rheumatoid -- blood
- Autoimmune Diseases -- blood
- Biological Assay
- Cells, Cultured -- drug effects
- Female
- Gene Expression Regulation -- drug effects
- Glycoproteins -- biosynthesis
- Humans
- Individuality
- Infliximab
- Infusions, Intravenous
- Interleukin-6 -- biosynthesis
- Male
- Middle Aged
- Osteoprotegerin
- Receptors, Cytoplasmic and Nuclear -- biosynthesis
- Receptors, Tumor Necrosis Factor -- biosynthesis
- Synovial Membrane -- drug effects
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- analysis
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.